Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v6-FR Version v1-EN
Language French English
Date Updated 2023-03-27 2023-02-16
Drug Identification Number 02473968 02473968
Brand name ODAN-SODIUM POLYSTYRENE SULFONATE ODAN-SODIUM POLYSTYRENE SULFONATE
Common or Proper name Sodium Polystyrene Sulfonate Oral/Rectal Suspension Sodium Polystyrene Sulfonate Oral/Rectal Suspension
Company Name ODAN LABORATORIES LTD ODAN LABORATORIES LTD
Ingredients SODIUM POLYSTYRENE SULFONATE SODIUM POLYSTYRENE SULFONATE
Strength(s) 250MG 250MG
Dosage form(s) SUSPENSION SUSPENSION
Route of administration RECTAL ORAL RECTAL ORAL RECTAL ORAL RECTAL ORAL
Packaging size 60 mL 60 mL
ATC code V03AE V03AE
ATC description ALL OTHER THERAPEUTIC PRODUCTS ALL OTHER THERAPEUTIC PRODUCTS
Reason for shortage Demand increase for the drug. Demand increase for the drug.
Anticipated start date
Actual start date 2023-02-15 2023-02-15
Estimated end date 2023-03-30 2023-03-30
Actual end date 2023-03-24
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments current inventory on allocation current inventory on allocation
Health Canada comments